… Molnupiravir is an oral antiviral drug that received Emergency Use Authorization in … COVID-19.
The aim of this systematic review was to find out the safety and efficacy of Molnupiravir in …

… Molnupiravir is a newer oral antiviral drug that has recently been tested in COVID-19. We
aim to … of literature to find out the efficacy and safety of molnupiravir in patients with COVID-19. …

… action, safety, efficacy, and clinical trials of molnupiravir in the treatment of COVID-19 patients.
… We aimed to review the clinical evidence about the safety and efficacy of the molnupiravir …

… In conclusion, our study supports the use of molnupiravir in non-hospitalized patients with
COVID-19. Further research should be focused on evaluating its comparative efficacy in …

… These sensitivity analyses indicate that the antiviral efficacy demonstrated in … of molnupiravir
as an oral agent to reduce infectious virus replication and interrupt progression of COVID-19 …

… widely-used coronavirus treatments. To estimate its antiviral efficacy of Molnupiravir, we built
… We find that the antiviral efficacy of Molnupiravir to stop the growth of the virus is 0.56 (95% …

… the efficacy and safety of treatment with molnupiravir started … Covid-19 and at least one
risk factor for severe Covid-19 … of molnupiravir or placebo twice daily for 5 days. The primary …

… efficacy of molnupiravir among mild or moderate COVID-19 … records were “Molnupiravir,”
“COVID-19,” and “efficacy.” This … of molnupiravir with a placebo for COVID-19 treatment. The …

… results to investigate the mechanism of Molnupiravir-induced COVID-19 mutagenesis. This
… The conducted preclinical and clinical studies confirm the efficacy and safety of Molnupiravir …

… conducted to assess the clinical efficacy of molnupiravir in treating patients with COVID-19. …
of molnupiravir use for nonhospitalized patients with COVID-19. However, molnupiravir did …